Share this post on:

Product Name :

Search keywords :

drugId :

Target Vo:
Bcr-Abl tyrosine kinase

Target Vo Short Name :

Bcr-Abl tyrosine kinase inhibitors

First Approval Country :
Mainland China

First Approval Date Filter:

Origin Company_Name :
Guangzhou Institute Of Biomedicine And Health, Chinese Academy Of Sciences

Active Company_Name :
Ascentage Pharma Group Inc

Active Indication_Name:
Leukemia, Myelogenous, Chronic

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites:
Popular product recommendations:
Alexa Fluor® 647-conjugated AffiniPure Goat Anti-Rabbit IgG H&L
p53 (acetyl K370)Antibody
Phospho-c-Jun (Ser73) Antibody: Phospho-c-Jun (Ser73) Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 36 kDa, targeting to Phospho-c-Jun (Ser73). It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat.

Share this post on:

Author: Betaine hydrochloride